First human test of new Huntington's disease injection begins
Disease control
Completed
This early study tested a new drug called ER2001, given by IV injection, in 10 adults with early Huntington's disease. The main goal was to check the safety of different doses and see how the drug moves through the body. Researchers also looked for early signs that the drug might…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC